Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction of Echinacea with Darunavir/Ritonavir in HIV
NCT01046890Phase 4Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Jan 2010
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of darunavir in human immunodeficiency virus infection (HIV), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Plasma concentration of darunavir and ritonavir at Day 14. Started Jan 2010; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01046890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046890.